Shanghai SIMR Biotechnology Co., Ltd.

Chinese venture capital and private equity firms have rushed to pick up stakes in both preclinical- and clinical-stage biotechs for a combined CNY1.5bn ($212m) over the past month, which seemed to buc

Shanghai-based Abbisko Therapeutics Co., Ltd. and Sichuan Huiyu Pharmaceutical Co., Ltd. have become the latest Chinese biopharmaceutical companies to go public, maintaining the strong fundraising m